If you are having trouble viewing this email, view online version .

ESE News Alert - 05 October 2020

Wearable glucose monitor may improve diabetes management

A new device worn on the stomach can continuously monitor blood glucose levels in people with diabetes and could help improve diabetes management.


Scientists discover potential new treatment for breast cancer

A team of Irish scientists may have discovered a potential new treatment option for patients with breast cancer who are resistant to hormone therapy, according to a study published in the journal Cancer Research.


Vitamin D supplements may protect from COVID-19

Sufficient levels of vitamin D are associated with reduced risk of infection and death from COVID-19, according to a study published in PLOS ONE.

Sky News

Diabetes in pregnancy linked to cardiovascular disease in children

Diabetes during pregnancy is associated with an increased risk of cardiovascular disease in children later in life, according to research published in Canadian Medical Association Journal.


The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected